Correlation Between CINTAS and Cumberland Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CINTAS and Cumberland Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CINTAS and Cumberland Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CINTAS P NO and Cumberland Pharmaceuticals, you can compare the effects of market volatilities on CINTAS and Cumberland Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CINTAS with a short position of Cumberland Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CINTAS and Cumberland Pharmaceuticals.

Diversification Opportunities for CINTAS and Cumberland Pharmaceuticals

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between CINTAS and Cumberland is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding CINTAS P NO and Cumberland Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cumberland Pharmaceuticals and CINTAS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CINTAS P NO are associated (or correlated) with Cumberland Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cumberland Pharmaceuticals has no effect on the direction of CINTAS i.e., CINTAS and Cumberland Pharmaceuticals go up and down completely randomly.

Pair Corralation between CINTAS and Cumberland Pharmaceuticals

Assuming the 90 days trading horizon CINTAS P NO is expected to generate 0.08 times more return on investment than Cumberland Pharmaceuticals. However, CINTAS P NO is 12.08 times less risky than Cumberland Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Cumberland Pharmaceuticals is currently generating about -0.34 per unit of risk. If you would invest  9,830  in CINTAS P NO on August 28, 2024 and sell it today you would lose (11.00) from holding CINTAS P NO or give up 0.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

CINTAS P NO  vs.  Cumberland Pharmaceuticals

 Performance 
       Timeline  
CINTAS P NO 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CINTAS P NO has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, CINTAS is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Cumberland Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cumberland Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

CINTAS and Cumberland Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CINTAS and Cumberland Pharmaceuticals

The main advantage of trading using opposite CINTAS and Cumberland Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CINTAS position performs unexpectedly, Cumberland Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cumberland Pharmaceuticals will offset losses from the drop in Cumberland Pharmaceuticals' long position.
The idea behind CINTAS P NO and Cumberland Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity